source
- Novo hikes guidance on Wegovy pill’s fast sales startIn its latest earnings report, the Danish drugmaker said sales and profit should shrink less than the company originally anticipated thanks to strong prescription numbers for its new obesity pill.BioPharma Dive · 3mo ago↗ source
- Why the FDA is authorizing fruit-flavored vapesMarty Makary says he was "skeptical initially" about flavored vapes but that age-gating technology could limit their use.STAT · 3mo ago↗ source
- Madrigal's Rezdiffra beats estimates; Gilead cuts jobs; Banyan debuts🚀 Madrigal Pharmaceuticals' MASH drug beats expectations: The biotech’s Rezdiffra sales came in at $311 million for the first quarter, surpassing analysts’ projections by about $10 million, accord…Endpoints